elopment and marketing of OPAXIO or may
not exercise its option with regard to pixantrone, and the risk factors
listed or described from time to time in the Company's filings with the
Securities and Exchange Commission including, without limitation, the
Company's most recent filings on Forms 10-K, 8-K, and 10-Q. Except as may
be required by Italian law, CTI is under no obligation to (and expressly
disclaims any such obligation to) update or alter its forward-looking
statements whether as a result of new information, future events, or
otherwise.
Media Contact:
Dan Eramian
T: 206.272.4343
C: 206.854.1200
F: 206.272.4434
E: media@ctiseattle.com
http://www.celltherapeutics.com/media.htm
Investors Contact:
Ed Bell
T: 206.282.7100
Lindsey Jesch
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
http://www.celltherapeutics.com/investors.htm
'/>"/>SOURCE Cell Therapeutics, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine news :1.
Queen Latifahs Travlin Light Tour to Be Sponsored by Jenny Craig2.
Cooper Clinic at Craig Ranch Opens Signaling the Next Phase of CooperLife Health-Focused Residential Community in McKinney3.
Jenny Craig Offers Help to Stranded Clients4.
Schering-Plough Board Elects Dr. Craig B. Thompson as a Director5.
Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post6.
J. Craig Venter, Human Genome Pioneer, to Receive Award at Vietnam Veterans of Americas National Leadership Conference7.
Jenny Craig Establishes License Agreement for Volumetrics(R)8.
VASAMED(R) Appoints Craig M. Walker, MD to Board of Directors9.
MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners10.
Audio from Medialink and Philips: Americas Dirty Mouths11.
AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush